Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...
ResMed (NYSE: RMD) finds itself in an investment limbo as revolutionary weight loss drugs create both immediate opportunities and long-term existential questions for the sleep apnea device maker.
Loud snoring at night. Pauses in breathing followed by gasps for air while you're asleep. Excessive daytime fatigue. Frequent nodding off in front of the TV or even when behind the wheel of a ...
Air Voel, a fast-growing Canadian provider of sleep therapy and respiratory care equipment, has announced the expansion of its nationwide distribution network for the highly in-demand ResMed AirSense ...
SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) launched today its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, ...
A new major manufacturing plant that opened in Singapore last quarter aims to greatly increase ResMed's production as more chips become available, CEO Mick Farrell said during the J.P. Morgan ...
ResMed (RMD) shares fell in the premarket on Wednesday after Morgan Stanley downgraded the respiratory device maker, citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results